Independent investigations and reviews into Guernsey’s health services have racked up a bill of nearly £188,000 over the past five years, according to newly released government figures.
The States of Guernsey’s Health & Social Care (HSC) Committee has confirmed that 20 separate reviews were commissioned either by or on behalf of the committee between 2021 and 2025. These reviews spanned a range of critical departments, including pathology, maternity, and ophthalmology, and carried a combined price tag of £187,479.
The disclosure came in response to a formal question from Deputy Gavin St Pier, who sought clarity on the number of reviews commissioned and their key findings. George Oswald, President of the HSC, provided the detailed breakdown, shedding light on the scale and scope of the investigations.
The Cost of Scrutiny: A Five-Year Breakdown
Over the five-year period, the HSC commissioned a diverse array of reviews, each designed to assess and improve the quality and safety of healthcare services on the island. The total expenditure of £187,479 reflects the fees paid to external organisations and experts brought in to conduct these independent assessments.
Oswald’s response highlighted that the reviews were not limited to a single area of concern but addressed a wide spectrum of services. Among the most notable were deep-dive investigations into the pathology department, maternity services, and ophthalmology, each of which had previously raised concerns among patients and staff alike.
Who Conducted the Reviews?
The reviews were carried out by a mix of highly respected professional bodies and independent consultants. This included the Royal College of Surgeons of England, the Isle of Man’s head of maternity, and several consultancy firms specialising in healthcare improvement.
Bringing in such external expertise ensures an unbiased perspective, but it comes at a cost. The involvement of royal colleges and senior clinical leaders from other jurisdictions underscores the seriousness with which the HSC has approached these reviews, even if the price tag has raised eyebrows among some politicians and members of the public.
Key Recommendations and Areas of Focus
While the full details of each report remain confidential in some cases, the HSC has shared a number of key recommendations that emerged from the reviews over the five-year period. These recommendations are now shaping the future of healthcare delivery in Guernsey.
One of the most significant areas of focus was the ear, nose, and throat (ENT) service. The review recommended the recruitment of additional consultants and increased locum cover to ensure the service could meet patient demand and reduce waiting times. This was seen as a critical step to stabilise a department that had been under pressure.
Another major theme was the resilience of the pathology department. Recommendations here centred on improving staffing levels and infrastructure to prevent service disruptions and ensure timely diagnostic results for patients across the island.
Beyond the Core Reviews
Oswald’s response also noted that two additional reports, which were not directly commissioned by or on behalf of the HSC, were conducted during the same period. These reports were nonetheless relevant to the committee’s services and have been considered as part of the broader improvement agenda.
This suggests that the true volume of scrutiny into Guernsey’s health services may be even higher than the headline figure of 20 reviews, as other bodies and committees have also commissioned work that touches on HSC responsibilities.
Public and Political Reaction
The revelation of the £187,479 spend has sparked debate among politicians and residents. Some argue that such investment is necessary to ensure high standards of care and patient safety, particularly in the wake of past failings. Others question whether the money could have been better spent on frontline services, given the ongoing pressures on health budgets.
Deputy Gavin St Pier, who tabled the question, has previously been a vocal advocate for transparency in health matters. His request for a detailed breakdown of the reviews and their findings reflects a broader push for accountability in how public funds are used.
What Happens Next?
With the reviews complete, the focus now shifts to implementation. The HSC has committed to acting on the recommendations, though progress may be gradual due to financial and staffing constraints. The committee has acknowledged that some changes, such as recruiting additional consultants, will take time to deliver.
For islanders, the hope is that these reviews will lead to tangible improvements in the quality and reliability of healthcare services. The investment in external scrutiny is only worthwhile if it results in better outcomes for patients, and the HSC has pledged to keep the public informed as changes are rolled out.
Broader Context: A Pattern of Review?
This is not the first time Guernsey’s health services have come under the microscope. In recent years, there have been numerous reports and investigations into various aspects of care, from mental health to paediatric services. The latest figures suggest that independent review has become a recurring feature of healthcare governance on the island.
While this can be seen as a commitment to continuous improvement, it also raises questions about whether systemic issues are being adequately addressed or merely repeatedly identified. The HSC will need to demonstrate that the latest round of recommendations leads to lasting change rather than another cycle of reports and reviews.
Transparency and Trust
One of the key challenges for the HSC is balancing the need for confidentiality in sensitive reviews with the public’s right to know. Some reports, such as the review of paediatric services, have not been made public, citing patient confidentiality and other concerns. This has led to criticism from those who believe full transparency is essential to rebuild trust in the health service.
However, the HSC argues that the details of reviews are often shared with relevant stakeholders and that publication is considered on a case-by-case basis. The goal, they say, is to ensure that lessons are learned without compromising the privacy of individuals involved.
Looking Ahead: The Cost of Quality
As Guernsey continues to invest in its health services, the question of how much scrutiny is enough will remain a topic of debate. The £187,479 spent over five years is a significant sum, but it is a fraction of the overall health budget. Proponents of the reviews argue that the cost is justified if it prevents costly mistakes and improves patient outcomes.
For now, the HSC is focused on turning recommendations into action. The coming months will reveal whether the investment in independent review translates into visible improvements on the ground. Islanders will be watching closely to see if the promises of change are fulfilled.
